Literature DB >> 24038349

The fallacy of thresholds used in defining response and remission in depression rating scales.

Florian Naudet1, Bruno Millet, Jean Michel Reymann, Bruno Falissard.   

Abstract

Response and remission are determined by the proportion of people who fall below a threshold score on depression rating scales. This calculation implies a possibility of false positives (FP) and false negatives (FN) depending on sensitivity and specificity of the threshold used, but also on response and remission rates. A simulation illustrates the methodological consequences of this phenomenon in a comparative trial where response and remission rates differ between groups: the probability of being misclassified differs between groups, and measures of association (relative risk and odds ratio) are biased. Alternatives are proposed to cope with this misclassification bias.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Keywords:  major depressive disorder; misclassification bias; remission; response; threshold

Mesh:

Substances:

Year:  2013        PMID: 24038349      PMCID: PMC6878272          DOI: 10.1002/mpr.1393

Source DB:  PubMed          Journal:  Int J Methods Psychiatr Res        ISSN: 1049-8931            Impact factor:   4.035


  16 in total

1.  Concordance between clinician and patient ratings as predictors of response, remission, and recurrence in major depressive disorder.

Authors:  Boadie W Dunlop; Thomas Li; Susan G Kornstein; Edward S Friedman; Anthony J Rothschild; Ron Pedersen; Philip Ninan; Martin Keller; Madhukar H Trivedi
Journal:  J Psychiatr Res       Date:  2010-06-02       Impact factor: 4.791

Review 2.  Understanding sensitivity and specificity with the right side of the brain.

Authors:  Tze-Wey Loong
Journal:  BMJ       Date:  2003-09-27

3.  The MDP75: a new approach in the determination of the minimal clinically meaningful difference in a scale or a questionnaire.

Authors:  Bruno Falissard; Mickael Lukasiewicz; Emmanuelle Corruble
Journal:  J Clin Epidemiol       Date:  2003-07       Impact factor: 6.437

Review 4.  The effect of misclassification on the estimation of association: a review.

Authors:  Michael Höfler
Journal:  Int J Methods Psychiatr Res       Date:  2005       Impact factor: 4.035

5.  Is the cutoff to define remission on the Hamilton Rating Scale for Depression too high?

Authors:  Mark Zimmerman; Michael A Posternak; Iwona Chelminski
Journal:  J Nerv Ment Dis       Date:  2005-03       Impact factor: 2.254

6.  Estimating the effects of misclassification.

Authors:  T E Mertens
Journal:  Lancet       Date:  1993-08-14       Impact factor: 79.321

7.  Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence.

Authors:  E Frank; R F Prien; R B Jarrett; M B Keller; D J Kupfer; P W Lavori; A J Rush; M M Weissman
Journal:  Arch Gen Psychiatry       Date:  1991-09

8.  Implications of using different cut-offs on symptom severity scales to define remission from depression.

Authors:  Mark Zimmerman; Michael A Posternak; Iwona Chelminski
Journal:  Int Clin Psychopharmacol       Date:  2004-07       Impact factor: 1.659

Review 9.  Antidepressants versus placebo for depression in primary care.

Authors:  Bruce Arroll; C Raina Elley; Tana Fishman; Felicity A Goodyear-Smith; Tim Kenealy; Grant Blashki; Ngaire Kerse; Stephen Macgillivray
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08

10.  The improved Clinical Global Impression Scale (iCGI): development and validation in depression.

Authors:  Alane Kadouri; Emmanuelle Corruble; Bruno Falissard
Journal:  BMC Psychiatry       Date:  2007-02-06       Impact factor: 3.630

View more
  1 in total

1.  Efficacy and Safety of Transcranial Direct Current Stimulation as an Add-on Treatment for Bipolar Depression: A Randomized Clinical Trial.

Authors:  Bernardo Sampaio-Junior; Gabriel Tortella; Lucas Borrione; Adriano H Moffa; Rodrigo Machado-Vieira; Eric Cretaz; Adriano Fernandes da Silva; Renério Fraguas; Luana V Aparício; Izio Klein; Beny Lafer; Stephan Goerigk; Isabela Martins Benseñor; Paulo Andrade Lotufo; Wagner F Gattaz; André Russowsky Brunoni
Journal:  JAMA Psychiatry       Date:  2018-02-01       Impact factor: 21.596

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.